FDA Slams Drug Maker For Touting Unapproved Leukemia Treatment To Docs

Sep 8, 2016, 10:50 by Michael Croft

STAT | Celator touted its experimental drug for acute myeloid leukemia at a recent cancer conference, but the FDA says the company didn't have clearance to do so.

September 08, 2016 | Celator touted its experimental drug for acute myeloid leukemia at a recent cancer conference, but the FDA says the company didn't have clearance to do so. STAT